Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News BioStem Technologies Inc (ID) BSEM

Healthcare Biotechnology
BioStem Technologies, Inc., a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases. The company is also engages in the... see more

Current News ()

BioStem Technologies® to Debut American Amnion(TM) at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference

GlobeNewswire 1 day ago

BioStem Technologies Expands Product Access in Medicaid

GlobeNewswire November 25, 2025

BioStem Technologies Reports Third Quarter 2025 Financial Results

GlobeNewswire November 13, 2025

BioStem Technologies Announces Filing of Restated Financial Statements

GlobeNewswire November 13, 2025

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

GlobeNewswire November 5, 2025

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

GlobeNewswire November 5, 2025

BioStem Technologies Reports Positive Top-Line Clinical Results Demonstrating Superior Outcomes with BioRetain® Allograft in Diabetic Foot Ulcers

GlobeNewswire October 31, 2025

BioStem Technologies to Host Third Quarter 2025 Financial Results Conference Call on November 13, 2025

GlobeNewswire October 30, 2025

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

GlobeNewswire October 27, 2025
View More News ››

Opinion & Analysis ()

No current opinion is available.
View More Opinion ››

Bullboard Posts ()

RE:Spectacular Revenue Growth

Are you missing the fact that Trump tariffs mean BSEM lost the deal they announced November 24? So the whole Cdn sector is permanently...
KevinOleary - April 30, 2025

Spectacular Revenue Growth

Revenue up 794% in Q4 2024 versus Q4 2023.  That is incredible.  Expectations for continued explosive growth.  Profits up...
JuniorMiner2014 - January 21, 2025

Huge Alert $BSEM Research Report

The MedTech sector is often overlooked but is just as innovative as many of the top tech names. Two massive multi-billion-dollar...
stockpickmover1 - June 27, 2024
View more Bullboard ››

Kootenay Silver Inc.

Kootenay Silver Inc.

Kootenay Silver Inc., an exploration stage company, engages in the acquisition, exploration, and development of mineral ...
View More »